Harnessing the liver to induce antigen-specific immune tolerance
Open Access
- 5 May 2022
- journal article
- review article
- Published by Springer Nature in Seminars in Immunopathology
- Vol. 44 (4) , 475-484
Abstract
Autoimmune diseases develop when the adaptive immune system attacks the body’s own antigens leading to tissue damage. At least 80 different conditions are believed to have an autoimmune aetiology, including rheumatoid arthritis, type I diabetes, multiple sclerosis or systemic lupus erythematosus. Collectively, autoimmune diseases are a leading cause of severe health impairment along with substantial socioeconomic costs. Current treatments are mostly symptomatic and non-specific, and it is typically not possible to cure these diseases. Thus, the development of more causative treatments that suppress only the pathogenic immune responses, but spare general immunity is of great biomedical interest. The liver offers considerable potential for development of such antigen-specific immunotherapies, as it has a distinct physiological capacity to induce immune tolerance. Indeed, the liver has been shown to specifically suppress autoimmune responses to organ allografts co-transplanted with the liver or to autoantigens that were transferred to the liver. Liver tolerance is established by a unique microenvironment that facilitates interactions between liver-resident antigen-presenting cells and lymphocytes passing by in the low blood flow within the hepatic sinusoids. Here, we summarise current concepts and mechanisms of liver immune tolerance, and review present approaches to harness liver tolerance for antigen-specific immunotherapy.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 841)
This publication has 90 references indexed in Scilit:
- Nanoscale assemblies and their biomedical applicationsJournal of The Royal Society Interface, 2013
- Engineering antigens for in situ erythrocyte binding induces T-cell deletionProceedings of the National Academy of Sciences, 2012
- Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitisNature Biotechnology, 2012
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- Antigen-specific immunotherapy of autoimmune and allergic diseasesCurrent Opinion in Immunology, 2010
- In Hepatic Fibrosis, Liver Sinusoidal Endothelial Cells Acquire Enhanced ImmunogenicityThe Journal of Immunology, 2010
- Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific TregsJournal of Clinical Investigation, 2008
- Intrahepatic Murine CD8 T-Cell Activation Associates With a Distinct Phenotype Leading to Bim-Dependent DeathGastroenterology, 2008
- Mechanism of T cell tolerance induction by murine hepatic Kupffer cellsHepatology, 2008
- Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transferBlood, 2007